AI assistant
Sending…
CALIX, INC — Director's Dealing 2025
Jul 25, 2025
31174_dirs_2025-07-24_7f0ba050-a99d-4a51-ba91-ae48b642e5e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALIX, INC ((CALX))
CIK: 0001406666
Period of Report: 2025-07-22
Reporting Person: Weening Michael (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-22 | Common Stock | M | 92000 | $5.95 | Acquired | 107812 | Direct |
| 2025-07-22 | Common Stock | S | 92000 | $55 | Disposed | 15812 | Direct |
| 2025-07-23 | Common Stock | M | 92000 | $5.95 | Acquired | 107812 | Direct |
| 2025-07-23 | Common Stock | S | 92000 | $56 | Disposed | 15812 | Direct |
| 2025-07-23 | Common Stock | M | 16000 | $8.03 | Acquired | 31812 | Direct |
| 2025-07-23 | Common Stock | S | 16000 | $57 | Disposed | 15812 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-22 | Stock Option (right to buy) | $5.95 | M | 92000 | Disposed | 2027-12-29 | Common Stock (92000) | Direct |
| 2025-07-23 | Stock Option (right to buy) | $5.95 | M | 92000 | Disposed | 2027-12-29 | Common Stock (92000) | Direct |
| 2025-07-23 | Stock Option (right to buy) | $8.03 | M | 16000 | Disposed | 2029-02-14 | Common Stock (16000) | Direct |
Footnotes
F1: 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021.
F2: 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023.
More from CALIX, INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 22
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17